• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GIVEN IMAGING LTD., YOQNEAM PILLCAM PATENCY; SYSTEM, IMAGING, GASTROINTESTINAL, WIRELESS, CAPSULE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GIVEN IMAGING LTD., YOQNEAM PILLCAM PATENCY; SYSTEM, IMAGING, GASTROINTESTINAL, WIRELESS, CAPSULE Back to Search Results
Model Number UNKNOWN PILLCAM PATENCY CAPSUL
Device Problem Entrapment of Device (1212)
Patient Problems Aspiration/Inhalation (1725); Dyspnea (1816); Radiation Exposure, Unintended (3164)
Event Date 01/09/2020
Event Type  Injury  
Manufacturer Narrative
Title: patency capsule aspiration source intern med, volume 59, 2020 (1071-1073) article number: 7 date of advance publication: 09 january 2020.If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to literature source of study performed, a patient with anemia who had undergone two(2) abdominal surgeries for colon and gastric cancer, complained of respiratory distress, with a percutaneous arterial oxygen saturation of 90% at room air just after swallowing a patency capsule before endoscopy.Chest radiography and computed tomography revealed that the patency capsule was located within the bronchus intermedius so the patient was admitted for the removal of the patency capsule.The patency capsule was successfully retrieved by flexible bronchoscopy under local anesthesia, wherein the balloon was placed over the capsule and inflated.Subsequently, the catheter was pulled, while thus dragging the capsule with it and preventing damage.The patency capsule was removed seven(70 hours after aspiration, and the patient¿s respiratory symptoms diminished.
 
Manufacturer Narrative
Additional information: b5, g4.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to literature source of study performed (2019), a patient with anemia who had undergone two abdominal surgeries for colon and gastric cancer, complained of respiratory distress, with a percutaneous arterial oxygen saturation of 90% at room air just after swallowing a patency capsule before endoscopy.Chest radiography and computed tomography revealed that the patency capsule was located within the bronchus intermedius so the patient was admitted for the removal of the patency capsule.The patency capsule was successfully retrieved by flexible bronchoscopy under local anesthesia, wherein the balloon was placed over the capsule and inflated.Subsequently, the catheter was pulled, while thus dragging the capsule with it and preventing damage.The patency capsule was removed 7 hours after aspiration, and the patient¿s respiratory symptoms diminished.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PILLCAM PATENCY
Type of Device
SYSTEM, IMAGING, GASTROINTESTINAL, WIRELESS, CAPSULE
Manufacturer (Section D)
GIVEN IMAGING LTD., YOQNEAM
yetsira 13 street
yoqneam 20692
MDR Report Key10164481
MDR Text Key195480001
Report Number9710107-2020-00247
Device Sequence Number1
Product Code NEZ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup
Report Date 07/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUNKNOWN PILLCAM PATENCY CAPSUL
Device Catalogue NumberUNKNOWN PILLCAM PATENCY CAPSUL
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/01/2020
Initial Date FDA Received06/17/2020
Supplement Dates Manufacturer Received06/30/2020
Supplement Dates FDA Received07/22/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age77 YR
-
-